HPV & Military Service: Policy, Vaccination & Readiness

Human papillomavirus (HPV) infection does not disqualify from US military service. Current DoD policy focuses on prevention.

Current Policy (DoDI 6130.03 / Service-Specific)

• Accession: HPV infection alone — not disqualifying.
• Genital warts: If extensive/interfering with duty/equipment — temporary disqualification until resolved.
• Cervical dysplasia (ASCUS+): Requires evaluation; treatment completion before accession.
• HPV-related cancer: Disqualifying (history of).

Vaccination Program

• Strongly recommended: 2-dose (9–14yr) or 3-dose (15–45yr) series.
• Offered at: MEPS, basic training, periodic health assessments.
• Cost: Covered by TRICARE/DoD.
• Readiness rationale: Prevents genital warts (training time loss), cervical/anal/oropharyngeal cancers (long-term force health).

Epidemiology

• Service members: High-risk age group (18–26) for acquisition.
• Deployment: Increased sexual partners, reduced barrier use documented.
• Cost: DoD spends millions annually on HPV-related care.

Global Context

NATO allies have similar policies. Australia, UK, Canada integrate HPV vaccination into military health programs. WHO recommends universal vaccination — military populations benefit disproportionately due to demographics.